MagnaTerra Technologies raised $11 million in funding led by RFC Ambrian’s QCM Fund to further develop MR sensing technology for various applications.
Amount Raised
A$11 Million
Round Type
Funding Round
Investors
Description
Four Australian startups secured $22.2 million in funding this week, with MagnaTerra Technologies leading the charge with $11 million. The funding will assist in the development of MR sensors for critical minerals and defense applications. Investors include RFC Ambrian, Shaw and Partners, and others. This capital raise is crucial for the startup's international expansion goals.
Who else raised in Biotechnology around the same time
Companies in the same sectors as MagnaTerra Technologies that raised within 45 days of this round, from Fundz verified event records.
- Absco Therapeutics raised $5M on August 18, 2025.
- BioGene Therapeutics raised $250K on August 18, 2025.
- Anocca raised $46M (Funding Round) on August 18, 2025.
- Mirugen raised $3.3M (Seed) on August 18, 2025.
- CILA Therapeutics raised an undisclosed amount (Grant) on August 15, 2025.
- RIVANNA raised $800K (Grant) on August 15, 2025.
Who to call at MagnaTerra Technologies, and when
A new round usually means MagnaTerra Technologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day MagnaTerra Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MagnaTerra Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MagnaTerra Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MagnaTerra Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MagnaTerra Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.